Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Neurocrine Biosciences Stock Quote

Neurocrine Biosciences (NASDAQ: NBIX)

Price as of July 12, 2024, 4:00 p.m. ET

Neurocrine Biosciences Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
NBIX +53.52% +72.02% +11.45% +1,079%
S&P +24.51% +86.32% +13.24% +731%

Neurocrine Biosciences Company Info

Neurocrine Biosciences discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases.

News & Analysis

The Fool has written over 100 articles on Neurocrine Biosciences.


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.